JuraMed A/S: Financial statements 2022
CVR: 41885491
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JuraMed A/S (CVR 41885491) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -145,590 and a net result of DKK -70,451. Equity in the 2022 report amounted to DKK 298,893. The solvency ratio was 96.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -145,590
- Profit/Loss
- DKK -70,451
- Equity
- DKK 298,893
- Total Assets
- DKK 309,873
- Employees
- 1
Official annual report
Keep an eye on JuraMed A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 27, 2022, Revisor.dk ,Skørping, Godkendt Revisionsanpartsselskab has been appointed auditor of JuraMed A/S.
As of June 27, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of JuraMed A/S.
As of June 27, 2022, Uffe Brunø Lindstrøm has left the board of directors of JuraMed A/S.
As of June 27, 2022, PT HOLDING AF 27/6 ApS is registered as an owner of JuraMed A/S with an ownership share of 50%.
As of June 27, 2022, AJL Invest ApS is registered as an owner of JuraMed A/S with an ownership share of 50%.
JuraMed A/S has published its interim report for the period November 24, 2020 to December 31, 2021.
About JuraMed A/S
JuraMed A/S is a Danish company of the type Aktieselskab based in Aalborg, founded in 2020. The company is registered under the industry Inkassoaktiviteter og kreditoplysning. The management consists of Jørgen Hansen. The board consists of Adam Søholm Hansen (chair), Lucas Søholm Hansen and Per Thorgaard. The company is owned by PT HOLDING AF 27/6 ApS and AJL Invest ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 478,271 and a net result of DKK 350,929 compared with DKK -4,198 the year before. Equity in the 2025 report amounted to DKK 652,900.